Cargando…
Introduction of a remifentanil-based analgo-sedation protocol leads to a reduction of duration of mechanical ventilation and ICU stay in critically ill patients
Autores principales: | Van den Bosch, J, Van Bommel, J, Bakker, J, Gommers, D |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067035/ http://dx.doi.org/10.1186/cc9781 |
Ejemplares similares
-
Cost-consequence analysis of remifentanil-based analgo-sedation vs. conventional analgesia and sedation for patients on mechanical ventilation in the Netherlands
por: Al, Maiwenn J, et al.
Publicado: (2010) -
Remifentanil for postoperative analgo-sedation: effects on glycaemia and HOMA score
por: Chelazzi, C, et al.
Publicado: (2010) -
Weaning from mechanical ventilation using remifentanil versus midazolam–morphine analgo sedation: our experience
por: Nardo, M Di, et al.
Publicado: (2005) -
Consensus Statement on Analgo-sedation in Neurocritical Care and Review of Literature
por: Prabhakar, Hemanshu, et al.
Publicado: (2021) -
Remifentanil-based analgesia and sedation is well tolerated when administered for up to 10 days in mechanically ventilated ICU patients
por: Karabinis, A, et al.
Publicado: (2004)